pentobarbital will minimize the level or outcome of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Use of other therapies is strongly proposed when linagliptin would be to be administered by using a CYP3A4 inducerpentobarbital will lower the extent or influence of aprepitant by influencing hepatic/